LS Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

LS Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-192	Closed	-$19K	–	971
2014 Q4	$19K	Hold	192	–	–	﹤0.01%	769
2014 Q3	$18K	Hold	192	–	–	﹤0.01%	767
2014 Q2	$16K	Hold	192	–	–	﹤0.01%	773
2014 Q1	$15K	Hold	192	–	–	﹤0.01%	775
2013 Q4	$15K	Hold	192	–	–	﹤0.01%	819
2013 Q3	$13K	Hold	192	–	–	﹤0.01%	666
2013 Q2	$11K	Buy	+192	New	+$11.1K	﹤0.01%	696

Other funds holding IBB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BFA

Beaumont Financial Advisors Needham, Massachusetts $1.57B AUM 25.77% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

LS Investment Advisors's IBB Position: Q1 2015 in Review

LS Investment Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2015, closing a stake of 192 shares — an estimated $19K sold.

LS Investment Advisors first reported a position in IBB in Q2 2013 and held it in 7 quarters. The position peaked at $19K in Q4 2014. 400 funds tracked by Wall St. Rank hold IBB as of Q1 2015.

LS Investment Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2015 after selling out during the quarter.
LS Investment Advisors sold 192 iShares Biotechnology ETF shares in Q1 2015, an estimated $19K.
LS Investment Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 7 quarters.
LS Investment Advisors's iShares Biotechnology ETF position peaked at $19K in Q4 2014.
400 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2015.

Based on LS Investment Advisors's 13F filing for Q1 2015, filed 13 May 2015.